GH Research (GHRS) EBIT (2020 - 2025)
GH Research (GHRS) recorded quarterly EBIT of -$16.7 million in Q4 2025, down 0.92% quarter-over-quarter from -$16.6 million in Q3 2025, and down 29.15% on a YoY basis from -$23.6 million in Q4 2024.
GH Research (GHRS) EBIT (2020 - 2025) Analysis & Trends
GH Research's EBIT history runs 6 years deep, the most recent figure standing at -$16.7 million for Q4 2025.
- In Q4 2025, EBIT fell 29.15% year-over-year to -$16.7 million; the TTM figure through Dec 2025 stood at -$60.7 million (down 20.68% YoY), while the FY2025 annual figure was -$60.7 million, down 20.68% from the prior year.
- EBIT was -$16.7 million for Q4 2025 at GH Research, down from -$16.6 million in the prior quarter.
- In the past five years, EBIT ranged from a high of -$1.1 million in Q1 2021 to a low of -$16.7 million in Q4 2025.
- Historically, EBIT has averaged -$9.9 million across 5 years, with a median of -$10.2 million in 2023.
- The sharpest annual moves came in 2021 and 2025: EBIT slumped 7676.67% in 2021, then fell 10.44% in 2025.
- A 5-year view of EBIT shows it stood at -$6.6 million in 2021, then tumbled by 38.53% to -$9.2 million in 2022, then slipped by 21.66% to -$11.2 million in 2023, then declined by 16.0% to -$12.9 million in 2024, then dropped by 29.15% to -$16.7 million in 2025.
- The last three EBIT figures came in at -$16.7 million (Q4 2025), -$16.6 million (Q3 2025), and -$14.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -65.83 Mn |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - | -16.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -16.72 Mn |
| Sep 30, 2025 | -16.57 Mn |
| Jun 30, 2025 | -14.70 Mn |
| Mar 31, 2025 | -12.73 Mn |
| Dec 31, 2024 | -12.94 Mn |
| Sep 30, 2024 | -12.62 Mn |
| Jun 30, 2024 | -13.22 Mn |
| Mar 31, 2024 | -11.53 Mn |
| Dec 31, 2023 | -11.16 Mn |
| Sep 30, 2023 | -9.72 Mn |
| Jun 30, 2023 | -9.93 Mn |
| Mar 31, 2023 | -10.42 Mn |
| Dec 31, 2022 | -9.17 Mn |
| Sep 30, 2022 | -6.63 Mn |
| Jun 30, 2022 | -6.75 Mn |
| Mar 31, 2022 | -8.01 Mn |
| Dec 31, 2021 | -6.62 Mn |
| Sep 30, 2021 | -4.67 Mn |
| Jun 30, 2021 | -2.67 Mn |
| Mar 31, 2021 | -1.14 Mn |